Sorafenib: a guide to its use in advanced hepatocellular carcinoma

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.10, 2009-10, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas Pang Roberta Chan Pierre Poon Ronnie T

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

By Zhu Andrew X

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite

Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 537-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene Keating Gillian M.

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite